Background
Heart failure (HF) is a major global public health problem affecting millions of individuals worldwide. Despite advances in pharmacological and device-based therapies, heart failure remains associated with substantial morbidity, mortality, healthcare utilization, and impaired quality of life (QoL).
Objective
To evaluate the effectiveness of contemporary heart failure management strategies and their impact on patients' quality of life.
Methods
A retrospective observational study was conducted among 1,200 patients diagnosed with heart failure from January 2022 to December 2024 across four tertiary healthcare centers. Clinical outcomes, hospitalization rates, symptom burden, treatment adherence, and quality-of-life measures were assessed using the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Results
Patients receiving guideline-directed medical therapy (GDMT) demonstrated significantly improved quality-of-life scores (78.4 ± 12.3) compared with patients receiving conventional therapy (61.7 ± 14.8, p<0.001). Hospitalization rates decreased by 34%, while mortality decreased by 21% among patients with comprehensive disease management programs.
Conclusion
Integrated heart failure management strategies significantly improve patient outcomes and quality of life. Multidisciplinary approaches, medication optimization, telemonitoring, and patient education are essential components of successful heart failure care.